AJP - Heart Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 283: H2431-H2439, 2002. First published July 26, 2002; doi:10.1152/ajpheart.00865.2001
0363-6135/02 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/6/H2431    most recent
00865.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamishima, T.
Right arrow Articles by Quayle, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamishima, T.
Right arrow Articles by Quayle, J. M.
Vol. 283, Issue 6, H2431-H2439, December 2002

Mitochondrial Ca2+ uptake is important over low [Ca2+]i range in arterial smooth muscle

Tomoko Kamishima and John M. Quayle

Department of Human Anatomy and Cell Biology, University of Liverpool, Liverpool L69 3GE, United Kingdom


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Mitochondrial Ca2+ uptake is usually thought to occur only when intracellular Ca2+ concentration ([Ca2+]i) is high. We investigated whether mitochondrial Ca2+ removal participates in shaping [Ca2+]i signals in arterial smooth muscle over a low [Ca2+]i range. [Ca2+]i was measured using fura 2-loaded, voltage-clamped cells from rat femoral arteries. Both diazoxide and carbonyl cyanide m-chlorophenylhydrazone (CCCP) depolarized the mitochondria. Diazoxide application increased resting [Ca2+]i, suggesting that Ca2+ is sequestered in mitochondria. Over a low [Ca2+]i range, diazoxide and CCCP slowed Ca2+ removal rate, determined after a brief depolarization. When [Ca2+]i was measured during sustained depolarization to -30 mV, CCCP application increased [Ca2+]i. When Ca2+ transients were repeatedly evoked by caffeine applications, CCCP application elevated resting [Ca2+]i. Caffeine-induced Ca2+ transients were compared before and after CCCP application using the half decay time, or time required to reduce increase in [Ca2+]i by 50% (t1/2). CCCP treatment significantly increased t1/2. These results suggest that Ca2+ removal to mitochondria in arterial smooth muscle cells may be important at a low [Ca2+]i.

carbonyl cyanide m-chlorophenylhydrazone; diazoxide; fura 2; rhodamine 123; sarcoplasmic reticulum


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

UNTIL RECENTLY, mitochondrial Ca2+ uptake was thought to occur only when cytosolic Ca2+ concentration ([Ca2+]i) became abnormally high. However, this traditional view is now being questioned. Several reports (7, 16, 34) provided strong evidence that mitochodria are an integral part of Ca2+ regulatory mechanisms in a variety of cell types. The key to the reevaluation of the role of mitochondria was the development of the two mitochondria-specific Ca2+-sensitive indicators recombinant aequorin and rhod 2. Rizzuto et al. (36) genetically engineered mitochondria-targeted aequorin and reported that Ca2+ in mitochondria is elevated during the generation of inositol 1,4,5-trisphosphate, a ubiquitous second messenger that releases Ca2+ from intracellular stores (35). Similarly, rhod 2, a positively charged Ca2+-sensitive dye that tends to accumulate into mitochondria, permitted direct detection of mitochondrial Ca2+ concentration changes in a wide range of cells (2, 6, 17, 31). These studies often suggested that mitochondria do not simply lower [Ca2+]i but modulate other Ca2+ regulatory mechanisms (7, 16, 34). In particular, one recurring theme is that mitochondria seem strategically positioned near the origin of Ca2+ sources and thus can sense localized Ca2+ changes. In turn, Ca2+ removal to neighboring mitochondria may modulate the behavior of Ca2+ permeable channels through feedback mechanisms (22). The hypothesis that mitochondria are positioned close to Ca2+ sources is also useful in explaining why mitochondria, thought to have low affinity for Ca2+, can sequester Ca2+ in the absence of very high [Ca2+]i. The complexity of the role of mitochondria, however, may mean that results obtained from one cell type may not be applicable to others where intracellular architecture or [Ca2+]i raising mechanisms are different. To date, relatively few studies (6, 31) have addressed the role of mitochondrial Ca2+ uptake by using arterial smooth muscle cells. Furthermore, increases in [Ca2+]i required to induce maximum contraction in arteries may be rather modest (29); yet to our knowledge, few studies so far examined Ca2+ uptake by mitochondria at a lower range of [Ca2+]i. Monteith and Blaustein (31) reported that a moderate increase in [Ca2+]i does not produce marked Ca2+ changes in the majority of mitochondria with the use of cultured rat aortic smooth muscle cells. Also, using rat pulmonary artery smooth muscle cells, Drummond and Tuft (6) reported elevation in mitochondrial Ca2+ when [Ca2+]i was raised to ~1 µM, a concentration perhaps rarely experienced under normal conditions.

The current study examines the role of mitochondria in Ca2+ handling in arterial smooth muscle cells. Ca2+ removal was studied using voltage-clamped single arterial smooth muscle cells dialyzed with the Ca2+-sensitive dye fura 2. Ca2+ transients were evoked by Ca2+ influx or Ca2+ release, and the effect of agents thought to prevent mitochondrial Ca2+ uptake was studied. Also, changes in mitochondria membrane potential were detected using rhodamine 123, and effects of drugs thought to modify mitochondrial potential were investigated. Our results suggest that mitochondrial Ca2+ uptake is activated during Ca2+ influx and Ca2+ release. Ca2+ sequestration to mitochondria seems to occur even when the elevation in [Ca2+]i is modest. In the presence of putative inhibitors of mitochondrial Ca2+ uptake, the Ca2+ removal rate over the lower range of [Ca2+]i was reduced. Moreover, the results suggest that Ca2+ content in mitochondria may influence Ca2+ load in the sarcoplasmic reticulum. Part of this study has been presented as an abstract (26).


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cell preparation. Male Sprague-Dawley rats (200-300 g) were made unconscious by exposure to an increasing concentration of CO2, and then euthanized by exsanguination in accordance with Schedule 1 of the Animals (Scientific Procedures) Act, 1986. The femoral arteries were dissected in a salt solution containing (in mM) 137 NaCl, 0.44 NaH2PO4, 0.42 Na2HPO4, 4.17 NaHCO3, 5.6 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, and 10 glucose (pH adjusted to 7.4 with NaOH) (23). Single smooth muscle cells were enzymatically dissociated in a low-Ca2+ salt solution containing (in mM) 80 Na glutamate, 55 NaCl, 6 KCl, 2 MgCl2, 0.2 CaCl2, 10 HEPES, 10 glucose, and 0.2 EDTA (pH was adjusted to 7.3 at room temperature so that at 35°C, it will be 7.4) (23). At 35°C, the femoral artery was first digested for 30 min with 1.7 mg/ml papain and 0.7 mg/ml dithioerythritol and then for 20 min with 1.7 mg/ml collagenase (type F) and 1 mg/ml hyaluronidase (type I-S). Single smooth muscle cells were obtained by triturating the artery with a fire-polished Pasteur pipette. The cell suspension was kept in a refrigerator at 2-8°C, and all experiments were carried out on the same day.

Electrophysiology and microfluorimetry. Voltage clamp was achieved using a conventional whole cell clamp technique (18). Under control conditions, the extracellular solution was composed of (in mM) 80 Na glutamate, 40 NaCl, 20 tetraethylammonium Cl, 1.1 MgCl2, 3 CaCl2, 10 HEPES, and 30 glucose (pH 7.4 with NaOH). The intracellular solution consisted of (in mM) 145 CsCl, 3 MgCl2, 3 Na2ATP, 10 HEPES, and 0.05 fura 2 pentapotassium (pH 7.2 with CsOH). Membrane currents were amplified using Axopatch 200B (Axon Instruments), filtered at 1 kHz, and sampled at 5 kHz using pCLAMP version 7 software (Axon Instruments). Stock solutions of all test drugs except caffeine were made with DMSO at 1,000-fold of final concentrations. All agents except caffeine were applied by perfusing the experimental chamber with appropriate bath solutions. An elevation in [Ca2+]i was induced by Ca2+ influx through voltage-dependent Ca2+ channels or by Ca2+ release from the sarcoplasmic reticulum. Ca2+ channels were activated either by 1.8-s depolarization to 0 mV from a holding potential of -70 mV or by sustained depolarization to -30 mV. Ca2+ release was triggered by rapid application of 20 mM caffeine using a U tube superfusion system (9). In this case, a cell was voltage clamped at -70 mV, and the U tube with a small hole in its apex was placed in close proximity. The bath solution was continuously perfused while caffeine-containing bath solution was run through the U tube. Outflow of the U tube was made larger than inflow. In this arrangement, caffeine-containing solution does not leak out from the hole. Outflow was fed through a solenoid valve before being finally discarded. When the valve is closed, the caffeine-containing solution is promptly ejected from the hole in the U tube, producing a caffeine concentration jump. The cell remains exposed to caffeine as long as the valve is closed. When the valve is reopened, the caffeine-containing solution resumes to run to waste, whereas caffeine in the experimental chamber is washed out. The valve was controlled by pCLAMP command. [Ca2+]i was measured with deltaRAM (Photon Technology International), as previously described (23). A single cell was alternately illuminated with UV light of 340 and 380 nm (bandpass 8 nm) at 100 Hz. Emission signals were detected at 510 nm (bandpass 40 nm). The dissociation constant (Kd) for fura 2 was calculated as 180 nM from in vitro calibration using intracellular solutions containing a range of known free Ca2+. The desired free Ca2+ was produced by adding required amount of CaCl2, calculated with software (Buffer version 1.0; Dr. R. Schubert, Universität Rostock, Germany), to 10 mM EGTA-buffered pipette solution. The fluorescence ratios in the absence of added CaCl2 (Rmin) and in the presence of saturating Ca2+ (Rmax) were determined from in vitro measurements. Conversion of ratios (R) to [Ca2+]i was carried out using the equation Kd(F0/Fs)(R - Rmin)/(Rmax - R), where F0 is the count at 380 nm with Rmin solution and Fs is that with Rmax solution (15, 33). Rmin and Rmax were decreased by 15% to adjust for viscosity (33). Background signal was measured for each cell after formation of a gigaohm seal and before formation of whole cell clamp mode. To measure mitochondrial membrane potential, cells were loaded with rhodamine 123 (10 µg/ml) for 10-15 min at room temperature (8). Cells were rinsed with dye-free solution consisting of (in mM) 80 Na glutamate, 55 NaCl, 6 KCl, 2 MgCl2, 0.2 CaCl2, 10 HEPES, and 10 glucose (pH 7.4 with NaOH). Cells were not voltage clamped in these experiments. The fluorophore was excited at 500 nm (25 nm bandpass), and emission signal was determined at 545 nm (35 nm band pass) with a frequency of 10 Hz. Rhodamine 123 signals were expressed as the relative fluorescence intensity against the photon counts at the beginning of experiments. Data were expressed as means ± SE of n cells. When appropriate, Student's paired t-test or one-way ANOVA, followed by Tukey's test as a post hoc analysis, was used to evaluate significant difference. All experiments were carried out at room temperature.

Drugs. Fura 2 pentapotassium salt and rhodamine 123 were purchased from Molecular Probes. Cyclopiazonic acid (CPA) was obtained from Calbiochem-Novabiochem. Diazoxide was purchased from Research Biochemicals International. Papain was obtained from Worthington Biochemical. All other agents were from Sigma or BDH.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Ca2+ removal profile of rat femoral artery smooth muscle cells. To investigate Ca2+ regulatory mechanisms, voltage-dependent Ca2+ channels were activated by depolarization to 0 mV from a holding potential of -70 mV (Fig. 1A, third trace). This maneuver evoked Ca2+ current (Fig. 1A, second trace) and elevated [Ca2+]i (Fig. 1A, first trace). On repolarization to -70 mV, increased [Ca2+]i returned to the resting level, allowing the examination of Ca2+ clearance (23, 25). A high-order polynomial equation was fitted to the declining phase of the Ca2+ transient, and Ca2+ removal rate was calculated as the negative derivative of the fit. The result is expressed as either a function of the measured [Ca2+]i (Fig. 1A, fourth trace, left) or time where time 0 is the instance of repolarization (Fig. 1A, fourth trace, right). These traces (Fig. 1A, fourth trace, left and right) exemplify a complex waveform obtained in about one-half of the control cells. In these cells, the Ca2+ removal was initially fast over higher [Ca2+]i but decreased as [Ca2+]i declined. Just before elevated [Ca2+]i returned to the resting level, however, an increase in Ca2+ removal occurred, appearing as an upward hump in the removal profile. This shape of Ca2+ clearance may be termed as "peak-trough-peak," or phase 1, phase 2, and phase 3 (23, 25, 30). Phase 3, a delayed increase in Ca2+ removal rate, was absent (Fig. 1B, fourth trace, left and right) in about one-half of the control cells. In the control cells that lack phase 3, raised [Ca2+]i seems to recover quickly (Fig. 1B, first trace). These two types of Ca2+ removal pattern will be further discussed later.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 1.   A: elevation in intracellular Ca2+ concentration ([Ca2+]i) (first trace) was triggered by depolarization to 0 mV from a holding membrane potential (VM) of -70 mV (third trace) due to Ca2+ influx through voltage-dependent Ca2+ channels (second trace). Ca2+ removal rate was calculated as the negative derivative of the polynomial fit to the declining phase of the Ca2+ transient (-d[Ca2+]i/dt). Ca2+ removal rate is shown as either a function of the measured [Ca2+]i (fourth trace, left) or time where time 0 is the instance of repolarization (fourth trace, right). Note an upward hump (phase 3), the delayed enhancement in Ca2+ removal. B: Ca2+ transient of a control cell where raised [Ca2+]i returned to the basal level quickly (first trace). As in A, the second and the third traces show the Ca2+ current (I) and the voltage protocol, respectively. In this example, phase 3 is largely diminished (fourth trace, right and left).

Mitochondrial Ca2+ sequestration examined by diazoxide application. The importance of mitochondria in Ca2+ regulation has now been acknowledged in many cell types (7, 16, 34), but their role in arterial smooth muscle remains unclear. First, we sought to establish that Ca2+ is indeed sequestered in mitochondria. Because Ca2+ is sequestered in mitochondria by virtue of negative potential in mitochondrial inner membrane (7, 16, 34), the agents that depolarize mitochondria should discharge stored Ca2+. We used 100 µM diazoxide to depolarize mitochondria. Although its mechanism has yet to be fully established, there is evidence showing that, in cardiac myocytes, diazoxide depolarizes mitochondria and raises [Ca2+]i (see DISCUSSION). When diazoxide was applied to the cells voltage clamped at -70 mV, elevation in [Ca2+]i was not always observed. This may not be surprising because without prior stimulation, Ca2+ in mitochondria is probably not much higher than [Ca2+]i (31). Therefore, the cells were subjected to a brief depolarization to evoke a Ca2+ transient before the application of diazoxide. The Ca2+ efflux from the mitochondria may be a slow process in smooth muscle cells (6), and thus Ca2+ in mitochondria may remain elevated even when the global [Ca2+]i is already returned to the resting level (6). Figure 2 shows one such experiment. [Ca2+]i was first raised by depolarization (Fig. 2, left). Subsequent diazoxide application elevated [Ca2+]i, whereas the membrane potential was maintained at -70 mV (Fig. 2, right). The time gap between the left trace and the right trace in Fig. 2 was ~30 s. Diazoxide-induced elevation in [Ca2+]i was observed in all cells subjected to prior voltage pulse, with an average [Ca2+]i increase of 90 ± 20 nM (n = 7). The results suggest that mitochondria can in fact accumulate Ca2+ during Ca2+ influx and their Ca2+ remains sufficiently high even after global [Ca2+]i returned to the resting level.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 2.   Application of 100 µM diazoxide triggered a Ca2+ transient. The cell was subjected to a depolarizing pulse (bottom left) to elevate [Ca2+]i (top left). After [Ca2+]i returned to resting level, diazoxide was applied (downward arrow), triggering an increase in [Ca2+]i (top right), whereas VM was maintained at -70 mV (bottom right). The time gap between the left trace and the right trace was ~30 s.

Ca2+ removal profile determined in the presence of mitochondrial depolarizing agents. When depolarized, mitochondria no longer sequester Ca2+ due to the diminished driving force on Ca2+. Thus the Ca2+ removal profile was examined in the presence of 100 µM diazoxide. When [Ca2+]i was raised by depolarization (Fig. 3A, third trace), it returned to the resting level slowly (Fig. 3A, first trace) without the upward hump in the Ca2+ removal profile (Fig. 3A, fourth trace). Similar results were obtained from four other cells. The inhibition of phase 3 in the diazoxide-treated cells is somewhat different from that in the control cells without phase 3. As shown in toad stomach cells (30), phase 3 occurs in femoral artery smooth muscle cells only when [Ca2+]i is elevated for long enough (23). After depolarization, the average time required to restore resting [Ca2+]i in the control cells with phase 3 was 49.9 ± 7.7 s (n = 7), whereas that of the control cells without phase 3 was 18.7 ± 2.7 s (n = 6). On the other hand, the average time required to restore basal [Ca2+]i in diazoxide-treated cells was 54.8 ± 10.2 s (n = 5). This seems long enough to evoke the delayed acceleration in Ca2+ removal, yet phase 3 was largely diminished.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 3.   A: Ca2+ removal profile of a cell treated with 100 µM diazoxide. A depolarization to 0 mV from a holding potential of -70 mV (third trace) triggered Ca2+ current (second trace) and concomitant Ca2+ transient (first trace). Elevated [Ca2+]i returned to the basal level slowly. Also, phase 3, an upward hump in the Ca2+ removal profile, is largely diminished (fourth trace, right and left). B: Ca2+ removal profile of a cell treated with 1 µM carbonyl cyanide m-chlorophenylhydrazone (CCCP). Similar results as in A are shown, with little delayed facilitation in Ca2+ removal rate (fourth trace, right and left).

The apparent inhibition of phase 3 by diazoxide was surprising. Phase 3 corresponds to lower range of [Ca2+]i (~100 nM, see Fig. 1A, fourth trace, left), whereas mitochondria are generally thought to function as a high-capacity, low-affinity Ca2+ buffer (31). In fact, it has been noted (23) that the inhibition of mitochondrial Ca2+ uptake reduced the maximum Ca2+ removal rate measured at the instance of repolarization when [Ca2+]i is highest. Because the mechanism of diazoxide action has not been fully elucidated (see DISCUSSION), it is possible that diazoxide might have modulated Ca2+ clearance through nonmitochondrial pathways. However, this seems unlikely because a well-established mitochondrial depolarizing agent also produced similar results. Ca2+ transients were evoked in the presence of 1 µM CCCP, a protonophore that collapses mitochondrial membrane potential. In the presence of CCCP, raised [Ca2+]i returned to the basal level slowly (Fig. 3B, first trace), yet the phase 3 was largely inhibited (Fig. 3B, fourth trace). Again, the average time required to restore resting [Ca2+]i seemed long enough at 34.6 ± 4.8 s (n = 14), but the delayed increase in Ca2+ removal hardly occurred.

Effect of mitochondrial depolarizing agent on steady-state [Ca2+]i. The inhibitory effect of diazoxide and CCCP on phase 3 over lower [Ca2+]i was surprising because mitochondria are generally thought to sequester Ca2+ when [Ca2+]i is high (31). Because the Ca2+ removal rates were examined after a large depolarizing pulse, it is possible that the putative mitochondrial role in Ca2+ clearance may be exaggerated. Unlike neurons or cardiac myocytes, many smooth muscle cells, including those from femoral arteries, do not fire action potential. Rather, stimulation produces smaller and sustained depolarization. During continued depolarization, a new level of [Ca2+]i is achieved, reflecting an altered balance between Ca2+ influx and Ca2+ removal. Previous studies (10, 24) showed that [Ca2+]i increased by ~100 nM during sustained depolarization. If mitochondrial Ca2+ uptake is important only when [Ca2+]i is raised sufficiently high, inhibition of mitochondrial Ca2+ removal would have little impact on steady-state [Ca2+]i. On the other hand, if mitochondrial Ca2+ clearance is also important over lower [Ca2+]i, steady-state [Ca2+]i may be affected by mitochondrial Ca2+ uptake inhibitors.

We examined the effect of CCCP on steady-state [Ca2+]i increase produced by constant depolarization. Figure 4 shows one such experiment. Membrane potential was gradually increased from -70 mV to -50 mV to -30 mV (Fig. 4, bottom trace), producing a slow and steady [Ca2+]i increase (Fig. 4, top trace). When 1 µM CCCP was applied (downward arrow) while the membrane potential was maintained at -30 mV, an increase in [Ca2+]i was observed. This elevation in [Ca2+]i was partially reversible after perfusion with CCCP-free bathing solution (upward arrow). Though the magnitude of [Ca2+]i increase was variable among cells, CCCP application elevated [Ca2+]i in all six cells tested with the average maximum increase of 280 ± 180 nM (n = 6). These results suggest that mitochondrial Ca2+ removal participates in shaping steady-state [Ca2+]i during sustained depolarization.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 4.   The effect of CCCP on steady-state [Ca2+]i. VM was increased from -70 to -50 to -30 mV (bottom trace), with concomitant increase in [Ca2+]i (top trace). When 1 µM CCCP was applied (downward arrow), [Ca2+]i increased. On washout of CCCP (upward arrow), partial recovery in elevated [Ca2+]i was observed.

Effect of mitochondrial depolarizing agent on caffeine-induced Ca2+ transient. When mitochondria act as a Ca2+ buffer, their location within the cell may be important. For example, Park et al. (32) have reported that the origin of Ca2+ influences which mitochondria, perinuclear, perigranular, or subplasmalemmal, will preferentially remove Ca2+ in pancreatic acinar cells. In arterial smooth muscle cells, elevation in [Ca2+]i may occur not only due to Ca2+ influx but also Ca2+ release from the sarcoplasmic reticulum. The results described so far show mitochondrial Ca2+ clearance after Ca2+ influx. This does not mean that mitochondrial Ca2+ uptake is also important when Ca2+ is released. Therefore, we examined the effect of CCCP on caffeine-induced Ca2+ transients. Caffeine is one of the standard agonists for sarcoplasmic reticulum Ca2+ release because it activates ryanodine receptors. While cells were being voltage clamped at -70 mV, 20 mM caffeine was applied for 1 s with the U tube superfusion system, as described in MATERIALS AND METHODS. This arrangement permitted reproducible caffeine-induced Ca2+ transients. Figure 5A shows one such experiment under control conditions. The solid squares below the [Ca2+]i trace indicate application of 20 mM caffeine. The duration of caffeine transients was somewhat variable among cells, probably reflecting variable efficiency of the drug washout. Nonetheless, Ca2+ transients obtained from the same cell were reproducible. For analysis purposes (see below), we discarded the first transient and used second, third, and sometimes fourth Ca2+ transients because in some cells the first Ca2+ transient was somewhat different from the rest.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of CCCP on Ca2+ transients induced by caffeine applications. A: caffeine applications evoked Ca2+ transients in the control cell. Caffeine (20 mM) was applied for 1 s at the time indicated by solid squares, producing multiple Ca2+ transients due to Ca2+ release. B: caffeine-induced Ca2+ transients before and after application of 1 µM CCCP. Ca2+ transients were triggered twice by caffeine application. Application of CCCP (downward arrow) evoked elevation in [Ca2+]i. Subsequent caffeine application induced prolonged Ca2+ transient. On the washout of CCCP (upward arrow), a decrease in resting [Ca2+]i was observed. When caffeine application was repeated, raised [Ca2+]i returned to the resting level more quickly than when CCCP was present.

The effect of CCCP on caffeine-induced Ca2+ transients was examined next. Figure 5B shows one such example. Caffeine was applied twice before the chamber was perfused with 1 µM CCCP-containing solution. The application of CCCP (downward arrow) triggered a transient elevation in [Ca2+]i. This observation was noted in four more cells with the mean maximum increase of 500 ± 317 nM (n = 5). When the caffeine application was repeated in the continued presence of CCCP, the duration of the transient was prolonged. When the cell was washed with CCCP-free solution (upward arrow), a small decrease in resting [Ca2+]i was noted and partial recovery in duration of caffeine-evoked transient was observed.

To compare caffeine-induced Ca2+ transients before and after application of 1 µM CCCP, the half decay time (t1/2) of the transient was measured. The increase in [Ca2+]i was determined as the difference between the resting [Ca2+]i and [Ca2+]i measured at the end of caffeine application. The instance of terminating caffeine application was taken as time 0, and the time required to reduce [Ca2+]i increase by 50% was measured as t1/2. In five cells tested, the mean t1/2 before CCCP application was 3.4 ± 0.2 s, significantly different from that after CCCP application (33.2 ± 7.5 s, P < 0.05, Student's paired t-test). This CCCP effect was partially reversible with the mean t1/2 of 9.0 ± 1.2 s after washout. On the other hand, in the control cells, the mean t1/2 of the second caffeine application (7.2 ± 2.0 s) was not significantly different from that of the third caffeine application (8.0 ± 1.7 s, n = 6, Student's paired t-test). These results suggests that mitochondria are important in Ca2+ removal when [Ca2+]i is raised by Ca2+ release.

Modulation of mitochondrial membrane potential. The results described above attempted to dissect mitochondrial contribution to Ca2+ homeostasis with the use of pharmacological interventions. CCCP and diazoxide were used to inhibit mitochondrial Ca2+ uptake. It was assumed that both agents prevent Ca2+ accumulation in the mitochondria by depolarizing the mitochondrial membrane. While this assumption is likely to be true for CCCP, a consensus regarding diazoxide actions is yet to be achieved (see DISCUSSION). Therefore, we sought evidence that both CCCP and diazoxide depolarized the mitochondrial membrane. Cells were loaded with rhodamine 123, a positively charged dye with a propensity to accumulate into mitochondria due to their negative membrane potential (8). When concentrated above threshold, quenching of the indicator occurs. On mitochondrial depolarization, dye moves out from the organelles, relieving quench, and thus increasing fluorescent signal. On the other hand, mitochondrial membrane hyperpolarization will decrease fluorescence intensity due to further concentration and thus quenching of the fluorophore. In our experiments, the fluorescent signals declined continuously, presumably due to dye bleaching and leaking. Nonetheless, changes in the fluorescence intensity were detected on application of agents. As shown in Fig. 6A, an application of CCCP (1 µM) produced an increase in fluorescent signal, suggesting depolarization of mitochondria and subsequent dye redistribution into the cytosol. This CCCP effect was reversible. Diazoxide (100 µM), on the other hand, produced a small increase in signal (Fig. 6B). This may not be surprising because the half-maximum dose of diazoxide is 65-96 µM in cardiac mitochondria (19), and thus 100 µM diazoxide is likely to cause a partial depolarization. On the other hand, application of CCCP is likely to cause near-complete depolarization of mitochondria. When a higher concentration of diazoxide (500 µM) was tested, a larger increase in fluorescence intensity was noted (Fig. 6C). We also examined the effect of oligomycin on rhodamine 123 fluorescence intensity. Unlike CCCP or diazoxide, oligomycin is expected to cause a small hyperpolarization of mitochondria (8) (see DISCUSSION). Indeed, application of 3 µM oligomycin produced a small decrease in fluorescence intensity, suggesting mitochondrial hyperpolarization (Fig. 6D). The effect of oligomycin was not reversible (8). These observations indicate that mitochondrial membrane potential is depolarized by CCCP and diazoxide and hyperpolarized by oligomycin.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 6.   Changes in mitochondria VM detected with rhodamine 123. Rhodamine 123 signals were expressed as relative fluorescence intensity against the photon counts at the beginning of experiments. Because the fluorescence signals continuously declined under our experimental condition, dotted lines were added to show the trend before the application of agents. A: application of 1 µM CCCP increased fluorescence intensity, suggesting mitochondrial membrane depolarization. B: application of 100 µM diazoxide caused a small increase in fluorescence intensity. C: a larger increase in signal was detected with an application of 500 µM diazoxide. D: application of 3 µM oligomycin caused a small decrease in fluorescence intensity, suggesting mitochondrial hyperpolarization.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The main finding of the current study is that mitochondrial Ca2+ removal occurs over a [Ca2+]i range usually thought to be too low for its action. When mitochondrial Ca2+ uptake was blocked by diazoxide or CCCP, phase 3 of Ca2+ removal corresponding to a lower range of [Ca2+]i was inhibited. Also, during sustained depolarization to -30 mV where [Ca2+]i increased modestly, application of CCCP raised [Ca2+]i. These findings are surprising because mitochondria are thought to sequester Ca2+ when [Ca2+]i is high (31). The [Ca2+]i corresponding to phase 3 is low, and the primary candidate for Ca2+ removal for this range of [Ca2+]i would be ATP-fueled Ca2+ pumps. In fact, it was reported in a previous study (23) on femoral artery smooth muscle cells that application of CPA, an inhibitor of the sarcoplasmic reticulum Ca2+ pump, diminished phase 3. Likewise, application of thapsigargin or ryanodine, both inhibitors of sarcoplasmic reticulum Ca2+ uptake, inhibited phase 3 in rat cerebral artery smooth muscle cells (25). This raises the question as to why mitochondrial Ca2+ uptake appears to operate over a [Ca2+]i range, where excess Ca2+ is thought to be removed by the sarcoplasmic reticulum. One possibility is that diazoxide and CCCP reduced phase 3 by triggering Ca2+-induced Ca2+ release (12). Ca2+ discharge from mitochondria may activate ryanodine receptors in the sarcoplasmic reticulum. This would render the sarcoplasmic reticulum "leaky," effectively blocking Ca2+ sequestration. However, this seems unlikely. Under this scenario, the inhibition of sarcoplasmic reticulum Ca2+ uptake would be transient. In the continuous presence of diazoxide or CCCP, mitochondria are unable to sequester Ca2+. Therefore, when Ca2+ discharge from mitochondria is completed, the sarcoplasmic reticulum should resume Ca2+ uptake. This was not the case. Another possibility is that mitochondria depolarization deprived the Ca2+ pump in the sarcoplasmic reticulum of ATP. The depolarized mitochondria may rather consume than produce ATP in an attempt to restore membrane potential (5). Furthermore, even if more than enough exogeneous ATP were available in the pipette solution, sarcoplasmic reticulum Ca2+ pumps may require mitochondria-generated "compartmentalized" ATP (37). To test this hypothesis, the effect of the ATP synthase inhibitor oligomycin (3 µM) was examined. Oligomycin blocks mitocondrial ATP production without depolarizing mitochondria, thus keeping the mitochondrial ability to sequester Ca2+ intact (5). Thus if oligomycin also blocks phase 3, this would suggest that diazoxide and CCCP indirectly inhibited the Ca2+ pump in the sarcoplasmic reticulum. On the other hand, if Ca2+ removal in the presence of oligomycin is more similar to that of the control, the effect of diazoxide and CCCP is not due to ATP depletion. When Ca2+ removal was examined in the presence of oligomycin, phase 3 was not inhibited. Rather, Ca2+ removal rate was faster in the presence of oligomycin at low [Ca2+]i. Figure 7 summarizes Ca2+ removal rates determined in the presence of CCCP, diazoxide, CPA, oligomycin, or no agent (control) at a [Ca2+]i of 75 nM. A significant difference (P < 0.01) was detected between oligomycin data and CCCP, diazoxide, or CPA data using one-way ANOVA, followed by Tukey's test for post hoc analysis. Interestingly, a statistically significant difference was not detected between the control cells and CCCP-, diazoxide-, or CPA-treated cells. This is presumably because about one-half of the control cells did not develop phase 3, as discussed earlier. The oligomycin effect was not seen when the cells were also treated with CPA (n = 3, data not shown).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 7.   Summary of Ca2+ removal rates determined under various conditions at [Ca2+]i of 75 nM. All average data were obtained from five cells except for control experiments (n = 11). One-way ANOVA was carried out and the subsequent Tukey's test detected significant differences (**P < 0.01) between CCCP and oligomycin, diazoxide, and oligomycin, and cyclopiazonic acid (CPA) and oligomycin.

The results with oligomycin argue against the hypothesis that diazoxide and CCCP inhibited phase 3 by ATP depletion. Also, the apparent facilitation of Ca2+ removal by oligomycin is puzzling. Perhaps the hypothesis originally suggested using cardiac myocytes (4) and then the portal vein (12) that mitochondrial Ca2+ content influences sarcoplasmic reticulum Ca2+ load may be useful. If Ca2+ is initially stored in mitochondria and then shuttled to the sarcoplasmic reticulum, agents depolarizing mitochondria will inhibit sarcoplasmic reticulum Ca2+ uptake due to reduced Ca2+ supply. On the other hand, oligomycin hyperpolarizes mitochondria, increases Ca2+ content in mitochondria, and facilitates Ca2+ supply to the sarcoplasmic reticulum. The hyperpolarization caused by oligomycin is expected to be small because the effect of oligomycin is due to prevention of proton reentry into mitochondria, a process normally producing a small mitochondrial depolarization. This is in fact the case, as shown in Fig. 6. Nonetheless, the small hyperpolarization by oligomycin was sufficient to significantly promote Ca2+ removal.

There is no doubt that more work has to be carried out for final validation of the hypothesis that the Ca2+ content of mitochondria influences that of the sarcoplasmic reticulum. It is possible that data presented here are biased against the Ca2+ removal mechanisms requiring enzymes because all experiments were carried out at room temperature. Moreover, whether or not the mitochondria sequester Ca2+ when [Ca2+]i is raised by physiological agonists, such as adrenergic agents, needs to be addressed in a future study. Also, our study is solely based on temporal analysis of [Ca2+]i that provides no spatial information. In this regard, it is interesting to note that, using HeLa and HEK-293 cells expressing genetically engineered cameleon indicators, Arnaudeau et al. (1) recently provided evidence that Ca2+ reuptake to the endoplasmic reticulum is facilitated by Ca2+ efflux from the adjacent mitochondria. The conclusion offered by Arnaudeau et al. (1), that mitochondria promote endoplasmic reticulum Ca2+ uptake by providing Ca2+, not ATP, is also consistent with our findings. At the moment, the hypothesis that some Ca2+ is transferred from mitochondria to sarcoplasmic reticulum in the rat femoral artery seems best to reconcile our observations.

In light of its clinical importance (see below), the mechanism of diazoxide action on mitochondria merits further discussion. Diazoxide is probably best known as an opener of ATP-sensitive K+ (KATP) channels found not only in the plasma membrane (3) but also in mitochondrial membranes (21). More importantly, it has been suggested that the opening of mitochondrial KATP channels may confer resistance against ischemia to the heart. If the heart is subjected to mild ischemia, it becomes profoundly resistant against subsequent and more serious ischemic episodes (14), a phenomenon known as cardiac ischemic preconditioning. Interestingly, pretreatment with KATP channel openers seems to mimic the protective effect of the ischemic preconditioning (14). To date, however, beyond the notion that KATP channel openers exert preconditioning-like effects through mitochondrial rather than salcolemmal KATP channels, there is little consensus regarding this subject. Diazoxide has been useful in studying preconditioning because it selectively opens mitochondrial KATP channels (11). Although it seems logical to assume that activation of mitochondrial KATP channels will depolarize mitochondria (28), a recent report (13) suggested that diazoxide depolarizes mitochondria by inhibiting respiratory chain complex II, not by opening KATP channels. Our results seem to support this notion that in some cell types diazoxide depolarizes mitochondria independent of mitochondrial KATP channel opening. In this study, diazoxide triggered elevation in [Ca2+]i and inhibited the phase 3 Ca2+ removal when cells were dialyzed with Cs+. Under this condition, the opening of mitochondrial KATP channels seems unlikely to produce mitochondria depolarization. Likewise, Kowaltowski et al. (27) reported that replacement of K+ in mitochondria bathing medium with Li+, another poorly permeant ion to K channels, had little effect on diazoxide actions. It should be noted, however, that these authors ascribed cardioprotective effects of KATP channel openers to mitochondrial volume regulation, not to depolarization (27). These authors also reported few inhibitory effects of diazoxide on mitochondrial Ca2+ uptake (27). Our results, however, suggest that diazoxide depolarizes the mitochondrial membrane, discharges stored Ca2+ and modulates the Ca2+ removal profile. These discrepancies may be explained in part by the difference in experimental methods and materials.

One unresolved important question is how mitochondria sequester Ca2+ over a low-[Ca2+]i range. In particular, during sustained depolarization to -30 mV, [Ca2+]i rarely reaches values high enough for low-affinity Ca2+ removal mechanisms to be activated. One possibility is that some mitochondria may be closely located to Ca2+ channels, sensing higher Ca2+ than bulk, averaged [Ca2+]i. This may, in turn, cause mitochondria to modulate Ca2+ influx. If Ca2+ near the cell membrane is cleared by the mitochondria, Ca2+-induced inactivation of voltage-dependent Ca2+ channels will be suppressed. Indeed, Ca2+ influx regulation by mitochondria acting as a Ca2+ sink has been suggested for Ca2+ channels in neurons (5) and Ca2+ release-activated Ca2+ channels in T lymphocytes (20).

In the present study, we provided evidence that mitochondria play an important role in Ca2+ regulation using rat femoral arterial smooth muscle cells. Mitochondrial Ca2+ clearance seems important over lower [Ca2+]i range because phase 3 was inhibited with mitochondrial depolarizing agents. Moreover, steady-state [Ca2+]i measured at a constant membrane potential of -30 mV was elevated on addition of CCCP. Unlike cardiac muscle, arteries do not generally fire action potentials and may require a rather small increase in [Ca2+]i to cause maximum contraction (29). Mitochondrial participation in shaping [Ca2+]i during sustained and modest depolarization, therefore, may have particular relevance in arterial smooth muscle cells. Also, CCCP significantly prolonged the duration of Ca2+ transients evoked by caffeine application, implying a mitochondrial role in Ca2+ homeostasis when [Ca2+]i is raised by Ca2+ release. Although further effort is required to completely elucidate mitochondrial contribution in Ca2+ regulation, the results described here may offer some insight in Ca2+ homeostasis in arterial smooth muscle cells.


    ACKNOWLEDGEMENTS

We thank Dr. Richard J. Evans (Department Cell Physiology and Pharmacology, University of Leicester) for help with the U tube superfusion system.


    FOOTNOTES

This study was supported by British Heart Foundation Grant FS/2000001 and Wellcome Trust Grant 055506. T. Kamishima is a British Heart Foundation Intermediate Fellow.

Address for reprint requests and other correspondence: T. Kamishima, Dept. of Human Anatomy and Cell Biology, Univ. of Liverpool, The Sherrington Bldgs., Ashton St., Liverpool L69 3GE, UK (E-mail: kamishi{at}liv.ac.uk).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

July 26, 2002;10.1152/ajpheart.00865.2001

Received 1 October 2001; accepted in final form 19 July 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Arnaudeau, S, Kelley WL, Walsh JVJ, and Demaurex N. Mitochondria recycle Ca2+ to the endoplasmic reticulum and prevent the depletion of neighboring endoplasmic reticulum regions. J Biol Chem 276: 29430-29439, 2001[Abstract/Free Full Text].

2.   Babcock, DF, Herrington J, Goodwin PC, Park YB, and Hille B. Mitochondrial participation in the intracellular Ca2+ network. J Cell Biol 136: 833-844, 1997[Abstract/Free Full Text].

3.   Babenko, AP, Aguilar-Bryan L, and Bryan J. A view of SUR/KIR 6.X, KATP channels. Annu Rev Physiol 60: 667-687, 1998[Web of Science][Medline].

4.   Bassani, JWM, Bassani RA, and Bers DM. Ca2+ cycling between sarcoplasmic reticulum and mitochondria in rabbit cardiac myocytes. J Physiol 460: 603-621, 1993[Abstract/Free Full Text].

5.   Budd, SL, and Nicholls DG. A reevaluation of the role of mitochondria in neuronal Ca2+ homeostasis. J Neurochem 66: 403-411, 1996[Web of Science][Medline].

6.   Drummond, RM, and Tuft RA. Release of Ca2+ from the sarcoplasmic reticulum increases mitochondrial [Ca2+] in rat pulmonary artery smooth muscle cells. J Physiol 516: 139-147, 1999[Abstract/Free Full Text].

7.   Duchen, MR. Contributions of mitochondria to animal physiology: from homeostatic sensor to calcium signalling and cell death. J Physiol 516: 1-17, 1999[Abstract/Free Full Text].

8.   Duchen, MR, and Biscoe TJ. Relative mitochondrial membrane potential and [Ca2+]i in type I cells isolated from the rabbit carotid body. J Physiol 450: 33-61, 1992[Abstract/Free Full Text].

9.   Evans, RJ, and Kennedy C. Characterization of P2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses. Br J Pharmacol 113: 853-860, 1994[Web of Science][Medline].

10.   Fleischmann, BK, Murray RK, and Kotlikoff MI. Voltage window for sustained elevation of cytosolic calcium in smooth muscle cells. Proc Natl Acad Sci USA 91: 11914-11918, 1994[Abstract/Free Full Text].

11.   Garlid, KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D'Alonzo AJ, Lodge NJ, Smith MA, and Grover GJ. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels: possible mechanism of cardioprotection. Circ Res 81: 1072-1082, 1997[Abstract/Free Full Text].

12.   Greenwood, IA, Helliwell RM, and Large WA. Modulation of Ca2+-activated Cl- currents in rabbit portal vein smooth muscle by an inhibitor of mitochondrial Ca2+ uptake. J Physiol 505: 53-64, 1997[Abstract/Free Full Text].

13.   Grimmsmann, T, and Rustenbeck I. Direct effects of diazoxide on mitochondria in pancreatic B-cells and on isolated liver mitochondria. Br J Pharmacol 123: 781-788, 1998[Web of Science][Medline].

14.   Gross, GJ, and Fryer RM. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ Res 84: 973-979, 1999[Abstract/Free Full Text].

15.   Grynkiewicz, G, Poenie M, and Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985[Abstract/Free Full Text].

16.   Hajnóczky, G, Csordás G, Madesh M, and Pacher P. The machinery of local Ca2+ signalling between sarco-endoplasmic reticulum and mitochondria. J Physiol 529: 69-81, 2000[Abstract/Free Full Text].

17.   Hajnóczky, G, Robb-Gaspers LD, Seitz MB, and Thomas AP. Decoding of cytosolic calcium oscillations in the mitochondria. Cell 82: 415-424, 1995[Web of Science][Medline].

18.   Hamill, OP, Marty A, Neher E, Sakmann B, and Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391: 85-100, 1981[Web of Science][Medline].

19.   Holmuhamedov, EL, Wang L, and Terzic A. ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria. J Physiol 519: 347-360, 1999[Abstract/Free Full Text].

20.   Hoth, M, Fanger CM, and Lewis RS. Mitochondrial regulation of store-operated calcium signaling in T lymphocytes. J Cell Biol 137: 633-648, 1997[Abstract/Free Full Text].

21.   Inoue, I, Nagase H, Kishi K, and Higuti T. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature 352: 244-247, 1991[Medline].

22.   Jouaville, LS, Ichas F, Holmuhamedov EL, Camacho P, and Lechleiter JD. Synchronization of calcium waves by mitochondrial substrates in Xenopus laevis oocytes. Nature 377: 438-441, 1995[Medline].

23.   Kamishima, T, Davies NW, and Standen NB. Mechanisms that regulate [Ca2+]i following depolarization in rat systemic arterial smooth muscle cells. J Physiol 522: 285-295, 2000[Abstract/Free Full Text].

24.   Kamishima, T, and McCarron JG. Depolarization-evoked increases in cytosolic calcium concentration in isolated smooth muscle cells of rat portal vein. J Physiol 492: 61-74, 1996[Abstract/Free Full Text].

25.   Kamishima, T, and McCarron JG. Ca2+ removal mechanisms in rat cerebral resistance size arteries. Biophys J 75: 1767-1773, 1998[Web of Science][Medline].

26.   Kamishima, T, and Quayle JM. Possible interaction between mitochondria and sarcoplasmic reticulum in Ca2+ removal (Abstract). Biophys J 80: 613A-614A, 2001.

27.   Kowaltowski, AJ, Seetharaman S, Paucek P, and Garlid KD. Bioenergetic consequences of opening the ATP-sensitive K+ channel of heart mitochondria. Am J Physiol Heart Circ Physiol 280: H649-H657, 2001[Abstract/Free Full Text].

28.   Liu, Y, Sato T, O'Rourke B, and Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97: 2463-2469, 1998[Abstract/Free Full Text].

29.   McCarron, JG, Crichton CA, Langton PD, MacKenzie A, and Smith GL. Myogenic contraction by modulation of voltage-dependent calcium currents in isolated rat cerebral arteries. J Physiol 498: 371-379, 1997[Abstract/Free Full Text].

30.   McGeown, JG, McCarron JG, Drummond RM, and Fay FS. Calcium-calmodulin-dependent mechanisms accelerate calcium decay in gastric myocytes from Bufo marinus. J Physiol 506: 95-107, 1998[Abstract/Free Full Text].

31.   Monteith, GR, and Blaustein MP. Heterogeneity of mitochondrial matrix free Ca2+: resolution of Ca2+ dynamics in individual mitochondria in situ. Am J Physiol Cell Physiol 276: C1193-C1204, 1999[Abstract/Free Full Text].

32.   Park, MK, Ashby MC, Erdemli G, Petersen OH, and Tepikin AV. Perinuclear, perigranular and sub-plasmalemmal mitochondria have distinct functions in the regulation of cellular calcium transport. EMBO J 20: 1863-1874, 2001[Web of Science][Medline].

33.   Poenie, M, Alderton J, Steinhardt R, and Tsien R. Calcium rises abruptly and briefly throughout the cell at the onset of anaphase. Science 233: 886-889, 1986[Abstract/Free Full Text].

34.   Rizzuto, R, Bernardi P, and Pozzan T. Mitochondria as all-round players of the calcium game. J Physiol 529: 37-47, 2000[Abstract/Free Full Text].

35.   Rizzuto, R, Brini M, Murgia M, and Pozzan T. Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science 262: 744-747, 1993[Abstract/Free Full Text].

36.   Rizzuto, R, Simpson AWM, Brini M, and Pozzan T. Rapid changes of mitochondrial Ca2+ revealed by specifically targeted recombinant aequorin. Nature 358: 325-327, 1992[Medline].

37.   Steenbergen, JM, and Fay FS. The quantal nature of calcium release to caffeine in single smooth muscle cells results from activation of the sarcoplasmic reticulum Ca2+-ATPase. J Biol Chem 271: 1821-1824, 1996[Abstract/Free Full Text].


Am J Physiol Heart Circ Physiol 283(6):H2431-H2439
0363-6135/02 $5.00 Copyright © 2002 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. M. Quayle, M. R. Turner, H. E. Burrell, and T. Kamishima
Effects of hypoxia, anoxia, and metabolic inhibitors on KATP channels in rat femoral artery myocytes
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H71 - H80.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B.-X. Zhang, X. Ma, W. Zhang, C.-K. Yeh, A. Lin, J. Luo, E. A. Sprague, R. H. Swerdlow, and M. S. Katz
Polyunsaturated fatty acids mobilize intracellular Ca2+ in NT2 human teratocarcinoma cells by causing release of Ca2+ from mitochondria
Am J Physiol Cell Physiol, May 1, 2006; 290(5): C1321 - C1333.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. Laporte, A. Hui, and I. Laher
Pharmacological Modulation of Sarcoplasmic Reticulum Function in Smooth Muscle
Pharmacol. Rev., December 1, 2004; 56(4): 439 - 513.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Kamishima and J. M. Quayle
P2 receptor-mediated Ca2+ transients in rat cerebral artery smooth muscle cells
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H535 - H544.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/6/H2431    most recent
00865.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamishima, T.
Right arrow Articles by Quayle, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamishima, T.
Right arrow Articles by Quayle, J. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online